US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 24, 2019 (8 years ago)

LET Gel 4%

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.

What was recalled

LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL Single Use Syringe, Rx only, US Compounding, 1270 Don's Lane, Conway, AR, 800-718-3588, Barcode 62295501303.

Recalling firm
US Compounding Inc
Origin
AR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0482-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lidocaine recalls

See all
Class II · Moderate risk Ongoing

Xylocaine

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0729-2026
Class II · Moderate risk Ongoing

Xylocaine

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0728-2026
Class II · Moderate risk Ongoing

Lidocaine HCl Injection

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0726-2026
Class III · Low risk Ongoing

Lidolog Kit

Reason Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Asclemed USA Inc. D-0713-2026
Class II · Moderate risk Ongoing

Lidocaine HCl Injection USP

Reason Lack of Assurance of Sterility

Asclemed USA Inc. D-0659-2026